- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
HHS Claims Big Gains on Readmissions, Hospital-Acquired Harms
The Obama administration says the number of Medicare patients returning to hospitals within 30 days fell further in 2013, amounting to 150,000 fewer readmissions since January 2012.
The Obama administration says the number of Medicare patients returning to hospitals within 30 days fell further in 2013, amounting to 150,000 fewer readmissions since January 2012.
HHS describes the progress on readmissions in a brief report out Wednesday that claims the administration's quality initiatives and partnerships have achieved significant successes, including a reduction in hospital-induced harms credited with saving 15,000 lives and $4 billion.
The all-cause readmissions rate, according to the report, has declined to 17.5% in the past two years after hovering between 19% and 19.5% since 2007. Under the Patient Protection and Affordable Care Act, hospitals' Medicare payments are docked for high rates of readmissions. The penalty rises to 3% in fiscal 2015.
Read the full story here: http://bit.ly/1s2VLPk
Source: Modern Healthcare
Advancing the Art of Medicine Through Partnership
April 29th 2025Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discuss the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Study Highlights Unmet Needs in Measuring Patient Experiences in Alopecia Areata
April 29th 2025Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported outcome measures (PROMs) specific to alopecia areata (AA), a common hair loss condition with substantial quality of life impacts.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
